Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis

NCT01943968 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.

NCT NCT01943968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01943968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis
Lead sponsor
Hillel Yaffe Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2013
Completion date
June 30, 2014
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis